Equity Profile
Post-Earnings Recap
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | -13.41% |
management commentary, guidance changes, and full analysis available with Pro.
| -13.41% |
Tone: Cautiously Optimistic
Management expressed cautious optimism regarding future growth despite current challenges. They highlighted their commitment to innovation in the genomics space.
Management noted ongoing challenges due to the pandemic.
They emphasized a focus on innovation and long-term growth.
Illumina's earnings report showed a miss on EPS, which contributed to a slight decline in stock price by 0.35%. The company is facing challenges due to the ongoing pandemic but remains focused on innovation and long-term growth strategies. Investors may be cautious as there was no guidance provided for future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
REALTY INCOME CORP REIT